Two Sigma Advisers’s IN8bio INAB Stock Holding History

Two Sigma Advisers’s Portfolio INAB Stock Details INAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-36,351	Closed	-$85.1K	–	1035
2025 Q4	$85.1K	Sell	36,351 -9,400	-21%	-$17.9K	﹤0.01%	2247
2025 Q3	$99.3K	Buy	+45,751	New	+$101K	﹤0.01%	2226

Other funds holding INAB

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

Two Sigma Advisers's INAB Position: Q1 2026 in Review

Two Sigma Advisers sold out of IN8bio (INAB) in Q1 2026, closing a stake of 36,351 shares — an estimated $85.1K sold.

Two Sigma Advisers first reported a position in INAB in Q3 2025 and held it in 2 quarters. The position peaked at $99.3K in Q3 2025. 19 funds tracked by Wall St. Rank hold INAB as of Q1 2026.

Two Sigma Advisers reported no remaining IN8bio position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 36,351 IN8bio shares in Q1 2026, an estimated $85.1K.
Two Sigma Advisers first reported a position in IN8bio in Q3 2025 and held it in 2 quarters.
Two Sigma Advisers's IN8bio position peaked at $99.3K in Q3 2025.
19 funds tracked by Wall St. Rank held IN8bio as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.